Biggest changeResults of Operations The following tables summarize our results of operations and the percent of net sales of line items included in our consolidated statements of operations (dollars in thousands): Fiscal years ended January 29, 2022 January 30, 2021 February 1, 2020 (52 weeks) (52 weeks) (52 weeks) Net sales $ 5,807,149 $ 4,920,202 $ 4,434,514 Cost of sales 3,380,539 2,813,464 2,527,995 Gross profit 2,426,610 2,106,738 1,906,519 Selling, general and administrative expenses 2,160,539 1,912,314 1,776,919 Indefinite-lived intangible impairment — — 19,000 Operating income 266,071 194,424 110,600 Interest income (62 ) (653 ) (335 ) Interest expense 77,397 219,083 253,018 Loss on extinguishment and modification of debt 20,838 17,549 — Other non-operating income (34,497 ) — — Income (loss) before income taxes and income from equity method investees 202,395 (41,555 ) (142,083 ) Income tax expense (benefit) 53,473 (3,337 ) (35,658 ) Income from equity method investees (10,883 ) (6,482 ) (2,441 ) Net income (loss) 159,805 (31,736 ) (103,984 ) Net loss attributable to noncontrolling interest (4,612 ) (5,253 ) (8,111 ) Net income (loss) attributable to Class A and B-1 common stockholders $ 164,417 $ (26,483 ) $ (95,873 ) Fiscal years ended January 29, 2022 January 30, 2021 February 1, 2020 (52 weeks) (52 weeks) (52 weeks) Net sales 100.0 % 100.0 % 100.0 % Cost of sales 58.2 57.2 57.0 Gross profit 41.8 42.8 43.0 Selling, general and administrative expenses 37.2 38.9 40.1 Indefinite-lived intangible impairment — — 0.4 Operating income 4.6 3.9 2.5 Interest income (0.0 ) (0.0 ) (0.0 ) Interest expense 1.3 4.4 5.7 Loss on extinguishment and modification of debt 0.4 0.3 — Other non-operating income (0.6 ) — — Income (loss) before income taxes and income from equity method investees 3.5 (0.8 ) (3.2 ) Income tax expense (benefit) 0.9 (0.1 ) (0.8 ) Income from equity method investees (0.2 ) (0.1 ) (0.1 ) Net income (loss) 2.8 (0.6 ) (2.3 ) Net loss attributable to noncontrolling interest (0.0 ) (0.1 ) (0.1 ) Net income (loss) attributable to Class A and B-1 common stockholders 2.8 % (0.5 )% (2.2 )% 48 Fiscal years ended January 29, 2022 January 30, 2021 February 1, 2020 (52 weeks) (52 weeks) (52 weeks) Operational Data: Comparable sales increase 18.9 % 11.4 % 3.9 % Total pet care centers (U.S. and Puerto Rico) at end of period 1,433 1,454 1,478 Total veterinarian practices at end of period 197 125 81 Adjusted EBITDA (in thousands) $ 591,478 $ 484,348 $ 424,547 Fiscal 2021 (52 weeks) Compared with Fiscal 2020 (52 weeks) Net Sales and Comparable Sales Fiscal years ended (dollars in thousands) January 29, 2022 January 30, 2021 $ Change % Change Consumables $ 2,533,755 $ 2,123,499 $ 410,256 19.3 % Supplies and companion animals 2,603,104 2,328,663 274,441 11.8 % Services and other 670,290 468,040 202,250 43.2 % Net sales $ 5,807,149 $ 4,920,202 $ 886,947 18.0 % Net sales increased $886.9 million, or 18.0%, to $5.81 billion in fiscal 2021 compared to net sales of $4.92 billion in fiscal 2020, driven by a 18.9% increase in our comparable sales.
Biggest changeComparing fiscal 2022 and fiscal 2021, our results included the following: • an increase in net sales from $5.81 billion to $6.04 billion, representing period-over-period growth of 3.9%; • comparable sales growth of 4.5%; • net income attributable to Class A and B-1 common stockholders of $90.8 million, compared to net income attributable to Class A and B-1 common stockholders of $164.4 million in the prior year; and • Net cash flows provided by operating activities decreased from $358.2 million in fiscal 2021 to $346.0 million in fiscal 2022. 49 Results of Operations The following tables summarize our results of operations and the percent of net sales of line items included in our consolidated statements of operations (dollars in thousands): Fiscal years ended January 28, 2023 January 29, 2022 January 30, 2021 (52 weeks) (52 weeks) (52 weeks) Net sales $ 6,035,967 $ 5,807,149 $ 4,920,202 Cost of sales 3,608,860 3,380,539 2,813,464 Gross profit 2,427,107 2,426,610 2,106,738 Selling, general and administrative expenses 2,201,548 2,160,539 1,912,314 Operating income 225,559 266,071 194,424 Interest income (1,032 ) (62 ) (653 ) Interest expense 101,643 77,397 219,083 Loss on extinguishment and modification of debt — 20,838 17,549 Other non-operating loss (income) 12,667 (34,497 ) — Income (loss) before income taxes and income from equity method investees 112,281 202,395 (41,555 ) Income tax expense (benefit) 35,347 53,473 (3,337 ) Income from equity method investees (12,976 ) (10,883 ) (6,482 ) Net income (loss) 89,910 159,805 (31,736 ) Net loss attributable to noncontrolling interest (891 ) (4,612 ) (5,253 ) Net income (loss) attributable to Class A and B-1 common stockholders $ 90,801 $ 164,417 $ (26,483 ) Fiscal years ended January 28, 2023 January 29, 2022 January 30, 2021 (52 weeks) (52 weeks) (52 weeks) Net sales 100.0 % 100.0 % 100.0 % Cost of sales 59.8 58.2 57.2 Gross profit 40.2 41.8 42.8 Selling, general and administrative expenses 36.5 37.2 38.9 Operating income 3.7 4.6 3.9 Interest income (0.0 ) (0.0 ) (0.0 ) Interest expense 1.6 1.3 4.4 Loss on extinguishment and modification of debt — 0.4 0.3 Other non-operating loss (income) 0.2 (0.6 ) — Income (loss) before income taxes and income from equity method investees 1.9 3.5 (0.8 ) Income tax expense (benefit) 0.6 0.9 (0.1 ) Income from equity method investees (0.2 ) (0.2 ) (0.1 ) Net income (loss) 1.5 2.8 (0.6 ) Net loss attributable to noncontrolling interest 0.0 0.0 (0.1 ) Net income (loss) attributable to Class A and B-1 common stockholders 1.5 % 2.8 % (0.5 )% Fiscal years ended January 28, 2023 January 29, 2022 January 30, 2021 (52 weeks) (52 weeks) (52 weeks) Operational Data: Comparable sales increase 4.5 % 18.9 % 11.4 % Total pet care centers (U.S. and Puerto Rico) at end of period 1,430 1,433 1,454 Total veterinarian practices at end of period 247 197 125 50 Fiscal 2022 (52 weeks) Compared with Fiscal 2021 (52 weeks) Net Sales and Comparable Sales Fiscal years ended (dollars in thousands) January 28, 2023 January 29, 2022 $ Change % Change Consumables $ 2,859,602 $ 2,533,755 $ 325,847 12.9 % Supplies and companion animals 2,370,913 2,603,104 (232,191 ) (8.9 %) Services and other 805,452 670,290 135,162 20.2 % Net sales $ 6,035,967 $ 5,807,149 $ 228,818 3.9 % Net sales increased $228.8 million, or 3.9%, to $6.04 billion in fiscal 2022 compared to net sales of $5.81 billion in fiscal 2021, driven by a 4.5% increase in our comparable sales.
Our business will be impacted by our ability to continue to understand and react to changing customer purchase trends 44 Customer Acquisition, Retention, and Spend Our business is impacted by our ability to successfully attract new customers to any one of our channels, build their loyalty to encourage return visits, and expand their spend with Petco across multiple purchase channels (e.g., pet care centers, e-commerce, and services) and categories (e.g., pet food, supplies, and companion animal).
Our business will be impacted by our ability to continue to understand and react to changing customer purchase trends Customer Acquisition, Retention, and Spend Our business is impacted by our ability to successfully attract new customers to any one of our channels, build their loyalty to encourage return visits, and expand their spend with Petco across multiple purchase channels (e.g., pet care centers, e-commerce, and services) and categories (e.g., pet food, supplies, and companion animal).
Selling, General, and Administrative Expense The following types of expenses are included in our selling, general, and administrative costs (“SG&A”): • payroll and benefit costs of pet care center employees and corporate employees; • occupancy and operating costs of pet care centers and corporate facilities; • depreciation and amortization related to pet care centers and corporate assets; • credit card fees; • store pre-opening and remodeling costs; • advertising costs; and 46 • other selling and administrative costs.
Selling, General, and Administrative Expense The following types of expenses are included in our selling, general, and administrative costs (“SG&A”): • payroll and benefit costs of pet care center employees and corporate employees; • occupancy and operating costs of pet care centers and corporate facilities; • depreciation and amortization related to pet care centers and corporate assets; • credit card fees; • store pre-opening and remodeling costs; • advertising costs; and • other selling and administrative costs.
Please read the discussion of these assets under “Critical Accounting Policies and Estimates.” Interest Expense Our interest expense in fiscal 2019, fiscal 2020, and a portion of fiscal 2021 was primarily associated with a term loan facility, a revolving credit facility, the Floating Rate Senior Notes (as defined herein), the 3.00% Senior Notes (as defined herein), and interest rate caps.
Please read the discussion of these assets under “Critical Accounting Policies and Estimates.” Interest Expense Our interest expense in fiscal 2020 and a portion of fiscal 2021 was primarily associated with a term loan facility, a revolving credit facility, the Floating Rate Senior Notes (as defined herein), the 3.00% Senior Notes (as defined herein), and interest rate caps.
For more information regarding these activities, refer to Note 8 , “ Senior Secured Credit Facilities ,” and Note 9, “ Senior Notes ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
For more information regarding these activities, refer to Note 7, “ Senior Secured Credit Facilities ,” and Note 9, “ Senior Notes ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
Recent Accounting Pronouncements Refer to Note 1, “ Summary of Significant Accounting Policies ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for information regarding recently issued accounting pronouncements. 58
Recent Accounting Pronouncements Refer to Note 1, “ Summary of Significant Accounting Policies ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for information regarding recently issued accounting pronouncements.
As we saw the major purchase trend shift and growth into areas like e-commerce, services, and veterinary care, we actively invested to build capabilities and offerings to effectively capitalize on the opportunity.
As we saw the major purchase trend shift and growth into areas like 46 e-commerce, services, and veterinary care, we actively invested to build capabilities and offerings to effectively capitalize on the opportunity.
We also enter certain short-term lease commitments, letters of credit and purchase obligations in the 53 normal course of business.
We also enter certain short-term lease commitments, letters of credit and purchase obligations in the normal course of business.
Non-GAAP Financial Measures Management and our board of directors review, in addition to GAAP (as defined herein) measures, certain non-GAAP financial measures, including Adjusted EBITDA, Free Cash Flow, and Net Debt, to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of capital.
Non-GAAP Financial Measures Management and our board of directors review, in addition to GAAP (as defined herein) measures, certain non-GAAP financial measures, including Adjusted EBITDA and Free Cash Flow to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of capital.
Our sales growth period-over-period was driven by our strong execution and differentiated product model across digital and in our pet care centers, coupled with an increase in new pet ownership and a resulting increase in sales to meet the needs of these pet parents.
Our sales growth period-over-period was driven by our strong execution and differentiated product model across digital and in our pet care centers, an increase in new pet ownership and a resulting increase in sales to meet the needs of these pet parents.
In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes. Because such a presentation would not reflect the adjustments made in our calculation of Adjusted EBITDA, we include our 50% interest in our Mexico joint venture on an Adjusted EBITDA basis to ensure consistency.
In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes. Because such a presentation would not reflect the adjustments made in the calculation of Adjusted EBITDA, we include the 50 percent interest in the company’s Mexico joint venture on an Adjusted EBITDA basis to ensure consistency.
Our multichannel, go-to-market strategy integrates our strong digital assets with our nationwide physical footprint to meet the needs of pet parents who are looking for a single source for all their pet’s needs.
Our multicategory, go-to-market strategy integrates our strong digital assets with our nationwide physical footprint to meet the needs of pet parents who are looking for a single source for all their pet’s needs.
From the nutrition and supplies pets need each day, to the services that keep them at optimal heath, Vital Care makes it easier and more affordable for pet parents to care for their pet’s health all in one place.
From the nutrition and supplies pets need each day, to the services that keep them at optimal health, Vital Care Premier makes it easier and more affordable for pet parents to care for their pet’s whole health all in one place.
Interest under the First Lien Term Loan is based on, at the Company’s option, either a base rate or Adjusted LIBOR, subject to a 0.75% floor, payable upon maturity of the LIBOR contract, in either case plus the applicable rate.
Interest on the First Lien Term Loan is based on, at the Company’s option, either a base rate or Adjusted Term SOFR, subject to a 0.75% floor, payable upon maturity of the SOFR contract, in either case plus the applicable rate.
Pet Industry Trends The U.S. pet care industry is large and growing, serving millions of households with pets, and represented a total addressable market of $119 billion in 2021. Since 2008, the industry has exhibited steady growth driven by an increase in the underlying pet population coupled with strong tailwinds associated with pet humanization.
Pet Industry Trends The U.S. pet care industry is large and growing, serving millions of households with pets, and represented a total addressable market of $133 billion in 2022. Since 2008, the industry has exhibited steady growth driven by an increase in the underlying pet population coupled with strong tailwinds associated with pet humanization.
These obligations impact our short-term and long-term liquidity and capital resource needs. Certain contractual obligations are reflected on the consolidated balance sheet as of January 29, 2022, while others are considered future obligations. Our contractual obligations primarily consist of operating leases and long-term debt and related interest payments.
These obligations impact our short-term and long-term liquidity and capital resource needs. Certain contractual obligations are reflected on the consolidated balance sheet as of January 28, 2023, while others are considered future obligations. Our contractual obligations primarily consist of operating leases and long-term debt and related interest payments.
A 10% difference in our actual valuation reserve at January 29, 2022 would have an insignificant effect on pre-tax loss in fiscal 2021. Additionally, we do not believe there is a 56 reasonable likelihood that there will be a material change in future estimates or assumptions we use to calculate our shrink reserve.
A 10% difference in our actual valuation reserve at January 28, 2023 would have an insignificant effect on pre-tax income in fiscal 2022. Additionally, we do not believe there is a reasonable likelihood that there will be a material change in future estimates or assumptions we use to calculate our shrink reserve.
In tandem with Petco Love (formerly the Petco Foundation), an independent nonprofit organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we have helped find homes for more than 6.5 million animals.
In tandem with Petco Love (formerly the Petco Foundation), an independent nonprofit organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we have helped find homes for nearly 7 million animals.
The base rate is the greater of the bank prime rate, federal funds effective rate plus 0.5% or Adjusted LIBOR plus 1.0%. The applicable rate is 2.25% per annum for a base rate loan or 3.25% per annum for an Adjusted LIBOR loan. Principal payments are $4.25 million quarterly and commence d on June 30, 2021.
The base rate is the greater of the bank prime rate, federal funds effective rate plus 0.5% or Adjusted Term SOFR plus 1.0%. The applicable rate is 2.25% per annum for a base rate loan or 3.25% per annum for an Adjusted Term SOFR loan. Principal and interest payments commenced on June 30, 2021. Principal payments are $4.25 million quarterly.
Prior Year Discussion of Results and Comparisons For information on fiscal 2019 results and similar comparisons, please read “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our previous Annual Report on Form 10-K filed with the SEC on April 5, 2021.
Prior Year Discussion of Results and Comparisons For information on fiscal 2021 results and similar comparisons, please read “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our previous Annual Report on Form 10-K filed with the SEC on March 24, 2022.
Historically, adjustments to our vendor income deferral have not been material. A 10% difference in our vendor income deferred at January 29, 2022 would have affected pre-tax loss by $2.7 million in fiscal 2021. We have not made any material changes in the accounting methodology we use to assess valuation allowances during the past three fiscal years.
Historically, adjustments to our vendor income deferral have not been material. A 10% difference in our vendor income deferred at January 28, 2023 would have affected pre-tax income by $3.1 million in fiscal 2022. We have not made any material changes in the accounting methodology we use to assess valuation allowances during the past three fiscal years.
Adjusted EBITDA We present Adjusted EBITDA, a non-GAAP financial measure, because we believe it enhances an investor’s understanding of our financial and operational performance by excluding certain material non-cash items, unusual or non-recurring items that we do not expect to continue in the future, and certain other adjustments we believe are or are not reflective of our ongoing operations and performance.
The non-GAAP financial measures presented may differ from similarly-titled measures used by other companies. 52 Adjusted EBITDA We present Adjusted EBITDA, a non-GAAP financial measure, because we believe it enhances an investor’s understanding of our financial and operational performance by excluding certain material non-cash items, unusual or non-recurring items that we do not expect to continue in the future, and certain other adjustments we believe are or are not reflective of our ongoing operations and performance.
Investing Activities Net cash used in investing activities was $237.1 million, $157.2 million, and $139.0 million for fiscal 2021, fiscal 2020, and fiscal 2019, respectively, and consisted primarily of capital expenditures supporting our growth and initiatives.
Investing Activities Net cash used in investing activities was $320.3 million, $237.1 million, and $157.2 million for fiscal 2022, fiscal 2021, and fiscal 2020, respectively, and consisted primarily of capital expenditures supporting our growth and initiatives.
Vendor Allowances We receive various forms of consideration from our merchandise vendors (vendor allowances). We receive vendor allowances, primarily in the form of cooperative advertising reimbursements, rebate incentives, prompt purchase discounts, and vendor compliance charges pursuant to agreements with certain vendors.
We receive vendor allowances, primarily in the form of cooperative advertising reimbursements, rebate incentives, prompt purchase discounts, and vendor compliance charges pursuant to agreements with certain vendors.
We are increasingly linking our offerings with membership programs such as Vital Care and pet health insurance that create deeper engagement with our customers, and with our Pals Rewards loyalty program members specifically, which members accounted for over 80% of transactions in fiscal 2021.
We are increasingly linking our offerings with membership programs such as Vital Care Premier and pet health insurance that create deeper engagement with our customers, and with our Vital Care Core loyalty program members specifically, which members accounted for over 85% of transactions in fiscal 2022.
In recent years, our world-class leadership team and our dedicated and passionate partners have transformed our business from a successful yet traditional retailer to a disruptive, fully integrated, omnichannel provider of holistic pet health and wellness offerings, including premium products, services, and veterinary care.
In recent years, we have transformed our business from a successful yet traditional retailer to a disruptive, fully integrated, omnichannel provider of holistic pet health and wellness offerings, including premium products, services, and veterinary care.
As a result, the method used by the Company’s management to calculate our Net Debt may differ from the methods used by other companies to calculate their net debt.
As a result, the method used by the Company’s management to calculate our Free Cash Flow may differ from the methods used by other companies to calculate their free cash flow.
Net Income (Loss) Attributable to Class A and B-1 Common Stockholders Net income attributable to Class A and B-1 common stockholders was $164.4 million for fiscal 2021 compared with a net loss attributable to Class A and B-1 common stockholders of $26.5 million for fiscal 2020.
Net Income (Loss) Attributable to Class A and B-1 Common Stockholders Net income attributable to Class A and B-1 common stockholders was $90.8 million for fiscal 2022 compared with a net income attributable to Class A and B-1 common stockholders of $164.4 million for fiscal 2021.
A 10% change in our self-insurance reserves at January 29, 2022 would have affected pre-tax loss by $8.5 million in fiscal 2021.
A 10% change in our self-insurance reserves at January 28, 2023 would have affected pre-tax loss by $8.6 million in fiscal 2022.
Cash Flows The following table summarizes our consolidated cash flows: Fiscal years ended (dollars in thousands) January 29, 2022 January 30, 2021 February 1, 2020 (52 weeks) (52 weeks) (52 weeks) Total cash provided by (used in): Operating activities $ 358,215 $ 268,615 $ 110,337 Investing activities (237,083 ) (157,185 ) (139,041 ) Financing activities (18,782 ) (146,608 ) (3,071 ) Net increase (decrease) in cash, cash equivalents and restricted cash $ 102,350 $ (35,178 ) $ (31,775 ) Operating Activities Our primary source of operating cash is sales of products and services to customers, which are substantially all on a cash basis, and therefore provide us with a significant source of liquidity.
Cash Flows The following table summarizes our consolidated cash flows: Fiscal years ended (dollars in thousands) January 28, 2023 January 29, 2022 January 30, 2021 (52 weeks) (52 weeks) (52 weeks) Total cash provided by (used in): Operating activities $ 346,003 $ 358,215 $ 268,615 Investing activities (320,324 ) (237,083 ) (157,185 ) Financing activities (33,842 ) (18,782 ) (146,608 ) Net (decrease) increase in cash, cash equivalents and restricted cash $ (8,163 ) $ 102,350 $ (35,178 ) Operating Activities Our primary source of operating cash is sales of products and services to customers, which are substantially all on a cash basis, and therefore provide us with a significant source of liquidity.
Income Tax Expense (Benefit) Our effective tax rate was 24.5% for fiscal 2021, resulting in income tax expense of $53.5 million, compared to an effective tax rate of 11.2% and income tax benefit of $3.3 million for fiscal 2020.
Income Tax Expense (Benefit) Our effective tax rate was 28.0% for fiscal 2022, resulting in income tax expense of $35.3 million, compared to an effective tax rate of 24.5% and income tax expense of $53.5 million for fiscal 2021.
The Company paid an additional $18.9 million of term loan principal payments in fiscal 2020. For more information regarding these activities, refer to Note 8 and Note 9 to the historical consolidated financial statements included elsewhere in this Annual Report on Form 10-K.
The Company paid an additional $18.9 million of term loan principal payments in fiscal 2020. For more information regarding these activities, refer to Note 7, “ Senior Secured Credit Facilities ,” and Note 8, “ Senior Notes ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
The terms under the ABL Revolving Credit Facility are substantially similar to those of the Amended Revolving Credit Facility . For more information regarding this indebtedness, refer to Note 8, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
For more information regarding this indebtedness, refer to Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
If management concludes, based on assessment of relevant events, facts, and circumstances, that it is more likely than not that a reporting unit’s fair value is greater than its carrying value, no further impairment testing is required. 57 If management’s assessment of qualitative factors indicates that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then a quantitative assessment is performed.
If management concludes, based on assessment of relevant events, facts, and circumstances, that it is more likely than not that a reporting unit’s fair value is greater than its carrying value, no further impairment testing is required.
Such non-GAAP financial measures are not calculated in accordance with GAAP and should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the most comparable GAAP measures. The non-GAAP financial measures presented may differ from similarly-titled measures used by other companies.
Such non-GAAP financial measures are not calculated in accordance with GAAP and should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the most comparable GAAP measures.
The increase in capital expenditures between the periods was primarily due to the build-out of our veterinary hospitals, innovation, capital expenditures for our new distribution center and enhanced supply chain capacity in response to our sales growth. In fiscal 2022, we expect to spend approximately $275 million to $325 million in capital expenditures.
The increase in capital expenditures between the periods was primarily due to the build-out of our veterinary hospitals, innovation, capital expenditures for our new distribution centers and enhanced supply chain capacity in response to our sales growth.
Sources of Liquidity Senior Secured Credit Facilities As of January 30, 2021, the Company had $1,678.1 million outstanding on the Amended Term Loan Facility and no balance on the Amended Revolving Credit Facility, which provided for senior secured financing of up to $500.0 million, subject to a borrowing base. 55 On March 4, 2021, the Company completed a refinancing transaction by entering into a $1,700 million secured term loan facility maturing on March 4, 2028 ( the “ First Lien Term Loan ”) and the ABL Revolving Credit Facility, which matures on March 4, 2026 and has availability of up to $500.0 million, subject to a borrowing base.
Sources of Liquidity Senior Secured Credit Facilities On March 4, 2021, the Company completed a refinancing transaction by entering into a $1,700 million secured term loan facility maturing on March 4, 2028 (the “First Lien Term Loan”) and the ABL Revolving Credit Facility, which matures on March 4, 2026 and has availability of up to $500.0 million, subject to a borrowing base.
Capital expenditures by category during the periods set forth below are as follows: Fiscal years ended (dollars in thousands) January 29, 2022 January 30, 2021 February 1, 2020 New and existing pet care center locations $ 140,721 $ 80,776 $ 100,394 Digital and information technology 57,319 68,232 51,358 Supply chain and other 41,070 10,552 5,154 Total capital expenditures $ 239,110 $ 159,560 $ 156,906 Financing Activities Net cash used in financing activities was $18.8 million for fiscal 2021, compared with $146.6 million used in financing activities in fiscal 2020 and $3.1 million used in financing activities in fiscal 2019.
In fiscal 2023, we expect to spend approximately $225 million to $250 million in capital expenditures. 56 Capital expenditures by category during the periods set forth below are as follows: Fiscal years ended (dollars in thousands) January 28, 2023 January 29, 2022 January 30, 2021 New and existing pet care center locations $ 146,432 $ 140,721 $ 80,776 Digital and information technology 78,611 57,319 68,232 Supply chain and other 52,977 41,070 10,552 Total capital expenditures $ 278,020 $ 239,110 $ 159,560 Financing Activities Net cash used in financing activities was $33.8 million for fiscal 2022, compared with $18.8 million used in financing activities in fiscal 2021 and $146.6 million used in financing activities in fiscal 2020.
Significant assumptions inherent in the valuation methodology are employed and include, but are not limited to, prospective financial information, royalty rates and discount rates. An impairment charge is recorded for the amount by which the carrying amount of the trade name exceeds its fair value.
Significant assumptions inherent in the valuation methodologies employed by the third party valuation firm could include, but are not limited to, prospective financial information, growth rates, discount rates and comparable multiples from publicly traded companies in similar industries. An impairment charge is recorded for the amount by which the carrying amount of the trade name exceeds its fair value.
These investments include: digital and e-commerce integration and expansion; enhanced supply chain capacity; data analytical capabilities; veterinary services; marketing and advertising; and our owned brands.
These investments include: expansion of our veterinary footprint, digital and e-commerce integration and expansion; enhanced supply chain capacity including additional distribution centers; data analytical capabilities; and marketing and advertising.
There was no other non-operating income or loss recognized during fiscal 2020. For more information regarding this activity, refer to Note 11 , “Fair Value Measurements,” to the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
For more information regarding this activity, refer to Note 10, “Fair Value Measurements,” to the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
This offering is further enhanced by a rapidly expanding, high quality, accessible, comprehensive veterinary care platform, which includes full-service veterinary hospitals, Vetco mobile clinics, and tele-health services. The full value of our health and wellness ecosystem is realized for customers through our Vital Care membership program.
This offering is further enhanced by a rapidly expanding, high quality, accessible, comprehensive veterinary care platform, which includes full-service veterinary hospitals, Vetco mobile clinics, and tele-health services.
Financing cash flows in fiscal 2021 primarily consisted of borrowings and repayments of debt in connection with the March 4, 2021 debt refinancing transaction discussed under “Sources of Liquidity” below. Financing cash flows in fiscal 2020 primarily consisted of repayments of debt in connection with the initial public offering that occurred on January 19, 2021.
Financing cash flows in fiscal 2020 primarily consisted of repayments of debt in connection with the initial public offering that occurred on January 19, 2021.
Other Non-Operating Income Other non-operating income was $34.5 million for fiscal 2021 and related to non-cash gains from the remeasurement of the fair value of our investment in Rover Group, Inc which began after the consummation of its merger with a publicly traded special purpose acquisition company in fiscal 2021.
These losses and gains relate to non-cash remeasurements of the fair value of our investment in Rover Group, Inc. which began after the consummation of its merger with a publicly traded special purpose acquisition company in fiscal 2021.
Gross Profit Gross profit increased $319.9 million, or 15.2%, to $2.43 billion in fiscal 2021 compared to gross profit of $2.11 billion for fiscal 2020. As a percentage of sales, our gross profit rate was 41.8% for fiscal 2021 compared to 42.8% for fiscal 2020. The increase in gross profit was due to the overall increase in net sales.
As a percentage of sales, our gross profit rate was 40.2% for fiscal 2022 compared to 41.8% for fiscal 2021. The increase in gross profit was due to the overall increase in net sales.
Prior to fiscal 2019, the veterinary joint venture was accounted for as an equity method investment. Executive Summary Our business transformation initiatives, accelerated by an increase in pet ownership and a shift in customer discretionary spend toward the pet category, have driven strong top-and bottom-line growth in our business.
Executive Summary Our business transformation initiatives, accelerated by an increase in pet ownership and a shift in customer discretionary spend toward the pet category, have driven strong top-and bottom-line results in our business.
The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA: Fiscal years ended January 29, 2022 January 30, 2021 February 1, 2020 (dollars in thousands) (52 weeks) (52 weeks) (52 weeks) Net income $ 21,773 $ 14,225 $ 8,662 Depreciation 15,679 12,249 11,298 Income tax expense 11,390 6,229 4,107 Foreign currency (gain) loss (431 ) 704 (406 ) Interest expense (income), net 5,263 4,740 4,793 EBITDA $ 53,674 $ 38,147 $ 28,454 50% of EBITDA $ 26,837 $ 19,074 $ 14,227 ( 2 ) Non-cash occupancy-related costs include the difference between cash and straight-line rent for all periods.
The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA: Fiscal years ended January 28, 2023 January 29, 2022 January 30, 2021 (dollars in thousands) (52 weeks) (52 weeks) (52 weeks) Net income $ 24,757 $ 21,773 $ 14,225 Depreciation 19,820 15,679 12,249 Income tax expense 9,409 11,390 6,229 Foreign currency (gain) loss (268 ) (431 ) 704 Interest expense, net 5,449 5,263 4,740 EBITDA $ 59,167 $ 53,674 $ 38,147 50% of EBITDA $ 29,584 $ 26,837 $ 19,074 (2) Store pre-opening and closing expenses were adjusted for periods prior to fiscal 2023.
However, if estimates of losses are inaccurate, we may be exposed to losses or gains that could be material. A 10% difference in our actual shrink reserve at January 29 , 202 2 would have affected pre-tax loss by $ 2.8 million in fiscal 202 1 .
However, if estimates of losses are inaccurate, we may be exposed to losses or gains that could be material. A 10% difference in our actual shrink reserve at January 28, 2023 would have affected pre-tax income by $3.5 million in fiscal 2022. 58 Vendor Allowances We receive various forms of consideration from our merchandise vendors (vendor allowances).
By leveraging our extensive physical network of 1,433 pet care centers across the U.S. and Puerto Rico, we are able to offer our comprehensive product and service offering in a localized manner with a meaningful last-mile advantage over much of our competition.
By leveraging our extensive physical network of pet care centers, we are able to offer our comprehensive product and service offering in a localized manner with a meaningful last-mile advantage over much of our competition. The full value of our health and wellness ecosystem is realized for customers through our Vital Care Premier membership program.
In addition, other companies in our industry may define Adjusted EBITDA differently, limiting its usefulness as a comparative measure. 51 The table below reflects the calculation of Adjusted EBITDA and Adjusted EBITDA Margin for the periods presented: Fiscal years ended January 29, 2022 January 30, 2021 February 1, 2020 (dollars in thousands) (52 weeks) (52 weeks) (52 weeks) Net income (loss) attributable to Class A and B-1 common stockholders $ 164,417 $ (26,483 ) $ (95,873 ) Interest expense, net 77,335 218,430 252,683 Income tax expense (benefit) 53,473 (3,337 ) (35,658 ) Depreciation and amortization 172,431 174,836 173,544 Income from equity method investees (10,883 ) (6,482 ) (2,441 ) Loss on extinguishment and modification of debt 20,838 17,549 — Indefinite-lived intangible impairment — — 19,000 Asset impairments and write offs 10,918 15,606 11,871 Equity-based compensation 49,265 12,915 9,489 Other non-operating income (34,497 ) — — Mexico joint venture EBITDA (1) 26,837 19,074 14,227 Store pre-opening expenses 14,765 9,228 10,325 Store closing expenses 5,028 7,782 4,068 Non-cash occupancy-related costs (2) 8,114 19,240 32,763 Non-recurring costs (3) 33,437 25,990 30,549 Adjusted EBITDA $ 591,478 $ 484,348 $ 424,547 Net sales $ 5,807,149 $ 4,920,202 $ 4,434,514 Net margin (4) 2.8 % (0.5 )% (2.2 )% Adjusted EBITDA Margin (4) 10.2 % 9.8 % 9.6 % ( 1 ) Mexico joint venture EBITDA represents 50% of the entity’s operating results for the periods presented, as adjusted to reflect the results on a basis comparable to our Adjusted EBITDA.
Details of these changes and a reconciliation of the definitions prior to fiscal 2023 to the go-forward definition is presented in the tables and related footnotes below. 53 The table below reflects the calculation of Adjusted EBITDA and Adjusted EBITDA Margin for the periods presented: Fiscal years ended January 28, 2023 January 29, 2022 January 30, 2021 (dollars in thousands) (52 weeks) (52 weeks) (52 weeks) Net income (loss) attributable to Class A and B-1 common stockholders $ 90,801 $ 164,417 $ (26,483 ) Interest expense, net 100,611 77,335 218,430 Income tax expense (benefit) 35,347 53,473 (3,337 ) Depreciation and amortization 193,828 172,431 174,836 Income from equity method investees (12,976 ) (10,883 ) (6,482 ) Loss on extinguishment and modification of debt — 20,838 17,549 Asset impairments and write offs 1,992 10,918 15,606 Equity-based compensation 60,784 49,265 12,915 Other non-operating loss (income) 12,667 (34,497 ) — Mexico joint venture EBITDA (1) 29,584 26,837 19,074 Store pre-opening expenses (2) 14,993 14,765 9,228 Store closing expenses (2) 5,168 5,028 7,782 Non-cash occupancy-related costs (3) 8,432 8,114 19,240 Acquisition-related integration costs (4) 15,314 — — Other costs (5) 25,790 33,437 25,990 Adjusted EBITDA, as defined through fiscal 2022 $ 582,335 $ 591,478 $ 484,348 Store pre-opening expenses (2) (14,993 ) (14,765 ) (9,228 ) Store closing expenses (2) (5,168 ) (5,028 ) (7,782 ) Non-cash occupancy-related costs (3) (8,432 ) (8,114 ) (19,240 ) Other costs (5) (22,973 ) (15,202 ) (20,535 ) Adjusted EBITDA, as defined beginning fiscal 2023 $ 530,769 $ 548,369 $ 427,563 Net sales $ 6,035,967 $ 5,807,149 $ 4,920,202 Net margin (6) 1.5 % 2.8 % (0.5 )% Adjusted EBITDA Margin, as defined through fiscal 2022 (6) 9.6 % 10.2 % 9.8 % Adjusted EBITDA Margin, as defined beginning fiscal 2023 (6) 8.8 % 9.4 % 8.7 % (1) Mexico Joint Venture EBITDA represents 50 percent of the entity’s operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA.
Loss on Extinguishment and Modification of Debt In fiscal 2021, the Company recognized $20.8 million of losses on the March 2021 refinancing of the Amended Term Loan Facility and Amended Revolving Credit Facility. In fiscal 2020, the Company recognized $17.5 million of losses on the partial extinguishment of debt in conjunction with the Company’s initial public offering.
Loss on Extinguishment and Modification of Debt In fiscal 2022, the Company did not recognize any losses on extinguishment or modification of debt. In fiscal 2021, the Company recognized $20.8 million of losses on the March 2021 refinancing of the Amended Term Loan Facility and Amended Revolving Credit Facility.
Cost of Sales and Gross Profit Gross profit is equal to our net sales minus our cost of sales. Gross profit rate measures gross profit as a percentage of net sales.
Net sales are driven by comparable sales, new pet center locations, and expanded offerings. 47 Cost of Sales and Gross Profit Gross profit is equal to our net sales minus our cost of sales. Gross profit rate measures gross profit as a percentage of net sales.
We cannot predict the duration or ultimate severity of COVID-19 or its ultimate long-term impact on the broader economy or our operations and liquidity. Please refer to the risk factors in Part I, Item 1A of this Annual Report on Form 10-K.
We cannot predict the duration or ultimate severity of these macroeconomic factors or the ultimate impact on our operations and liquidity. For more information regarding certain risks associated with these macroeconomic factors, please refer to the risk factors in Part I, Item 1A, "Risk Factors" of this Form 10-K.
Our liquidity as of January 29, 2022 was $649.8 million inclusive of cash and cash equivalents of $211.6 million and $438.2 million of availability on the ABL Revolving Credit Facility.
Our liquidity as of January 28, 2023 was $645.8 million inclusive of cash and cash equivalents of $201.9 million and $443.9 million of availability on the ABL Revolving Credit Facility.
Significant Components of Results of Operations Net Sales Our net sales comprise gross sales of products and services, net of sales tax and certain discounts and promotions offered to our customers, including those offered under our customer loyalty programs. Net sales are driven by comparable sales, new pet center locations, and expanded offerings.
Our partners represent the strength of our brand every day and are key to our ongoing growth. Significant Components of Results of Operations Net Sales Our net sales comprise gross sales of products and services, net of sales tax and certain discounts and promotions offered to our customers, including those offered under our customer loyalty programs.
Segment We operate under one reportable segment and support and serve pets and their parents through our integrated ecosystem of pet care centers, services, and e-commerce. Seasonality Our financial performance is not significantly impacted by seasonality, as the majority of our sales are generated by pet parents caring for their pets year-round.
Seasonality Our financial performance is not significantly impacted by seasonality, as the majority of our sales are generated by pet parents caring for their pets year-round.
The increase in consumables and supplies and companion animals sales between the periods was driven by the increase in new pets, our strategic investments in customer acquisition along with continued expansion of our product assortment.
The increase in consumables sales between the periods was driven in part by the increase in new pets, our strategic investments in customer acquisition and retention, continued expansion of our product assortment and a mix shift to more premium consumables, including fresh and frozen food.
The increase in SG&A expenses period-over-period was to support our growth as we continue to invest in marketing, infrastructure, and people.
As a percentage of net sales, SG&A expenses decreased from 37.2% in fiscal 2021 to 36.5% in fiscal 2022 reflecting operating leverage from net sales growth. The increase in SG&A expenses period-over-period was to support our growth as we continue to invest in people, infrastructure and marketing.
If the carrying value of net assets assigned to the reporting unit exceeds the fair value of the reporting unit, then we would record an impairment loss equal to the difference.
If the carrying value of net assets assigned to the reporting unit exceeds the fair value of the 59 reporting unit, then we would record an impairment loss equal to the difference. In cases where a quantitative test is performed, the fair value of our reporting unit is estimated using the assistance of a third-party valuation firm.
In addition, as a result of the COVID-19 pandemic, the industry experienced a significant increase in household pets and therefore demand, which is expected to be a tailwind for years to come.
In addition, as a result of the COVID-19 pandemic, the industry experienced a significant increase in household pets and therefore demand, which is expected to be a tailwind for years to come. Beginning in fiscal 2020, U.S. households welcomed millions of incremental new pets into their homes that will need to be fed, groomed, vaccinated, and treated during their lives.
(“Petco”, the “Company”, “we”, “our” and “us”) is a category-defining health and wellness company focused on improving the lives of pets, pet parents, and our own partners.
(“Petco”, the “Company”, “we”, “our” and “us”) is a category-defining health and wellness company focused on improving the lives of pets, pet parents, and our own partners. We have consistently set new standards in pet care while delivering comprehensive pet wellness products, services and solutions, and creating communities that deepen the pet-pet parent bond.
Purchase obligations and commitments consist of open purchase orders, non-cancellable commitments for information technology, marketing and other products and services used in the normal course of business as well as our commitment for naming rights to the baseball stadium. As of January 29, 2022, our purchase obligations and commitments were $507.5 million of which $454.4 million is considered short-term.
Refer also to further discussion on our debt refinancing transaction in “Sources of Liquidity” below. Purchase obligations and commitments consist of open purchase orders, non-cancellable commitments for information technology, marketing and other products and services used in the normal course of business as well as 55 our commitment for naming rights to the baseball stadium.
Net cash provided by operating activities was $358.2 million in fiscal 2021 compared with net cash provided by operating activities of $268.6 million in fiscal 2020.
This was partially offset by lower cash paid for advertising and lower cash payments on operating leases due to the timing of rent payments. Net cash provided by operating activities was $358.2 million in fiscal 2021 compared with $268.6 million in fiscal 2020.
Free Cash Flow Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets. Management believes that Free Cash Flow, which measures our ability to 52 generate additional cash from our business operations, is an important financial measure for use in evaluating the C ompany’s financial performance.
Management believes that Free Cash Flow, which measures our ability to generate additional cash from our business operations, is an important financial measure for use in evaluating the Company’s financial performance. Although other companies report their free cash flow, numerous methods exist for calculating a company’s free cash flow.
( 4 ) We define net margin as net income (loss) attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales.
(6) We define net margin as net income (loss) attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales. Free Cash Flow Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets.
Net sales during fiscal 2021 were impacted by inflation, as we have taken pricing actions to offset cost increases on some vendor-supplied product. Where possible, we have worked with our merchant partners to help offset cost input increases. In the aggregate, we have not experienced a material impact on units as a result of these actions.
Net sales during fiscal 2022 and fiscal 2021 were impacted by inflation and, where possible, we have worked with our merchant partners to help offset cost input increases.
Indefinite-lived trade name We consider the Petco trade name to be an indefinite-lived intangible asset, as we currently anticipate that this trade name will contribute cash flows to us indefinitely. We perform our annual impairment test during the fourth quarter of each year or whenever events or changes in circumstances indicate the carrying value may not be recoverable.
We perform our annual impairment test during the fourth quarter of each year or whenever events or changes in circumstances indicate the carrying value may not be recoverable. Management has the option to first perform a quantitative assessment of its trade name asset to determine whether it is necessary to perform a quantitative impairment test.
In cases where a quantitative test is performed, the fair value of our trade name is estimated using the assistance of a third-party valuation firm using the relief from royalty valuation method, a variation of the discounted cash flow approach.
We also have the option to bypass the qualitative assessment described above and proceed directly to quantitative assessment. In cases where a quantitative test is performed, the fair value of our trade name is estimated using the assistance of a third-party valuation firm.
In fiscal 2021, pet care center merchandise delivered growth of 15.4% with higher retail traffic and strong growth in all major categories, including consumables, supplies, and companion animals. Our e-commerce and digital sales increased 21.1% from fiscal 2020 to fiscal 2021, reflecting our expanded brand assortment, enhanced personalization and extended fulfillment options.
In fiscal 2022, pet care center merchandise delivered growth of 1.4% with higher retail traffic and strong growth. Strength in consumables continues to offset the impact of discretionary purchasing in supplies and companion animals. Our e-commerce and digital sales increased 10.5% from fiscal 2021 to fiscal 2022, driven by strength in our digital pharmacy and repeat customers.
Refer to Note 6 and Note 8 to the historical consolidated financial statements included elsewhere in this Annual Report on Form 10-K for amounts outstanding as of January 29 , 202 2 related t o operating leases and debt , respectively . Refer also to further discussion on our debt refinancing transaction in “S ources of L iquidity ” below.
Refer to Note 5, “ Leases ,” and Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for amounts outstanding as of January 28, 2023 related to operating leases and debt, respectively.
Significant assumptions inherent in these valuation methodologies are employed and include, but are not limited to, prospective financial information, growth rates, discount rates, and comparable multiples from publicly traded companies in similar industries. We have not made any material changes in the accounting methodology we use to assess goodwill impairment losses during the past three fiscal years.
Significant assumptions inherent in the valuation methodologies employed by the third party valuation firm could include, but are not limited to, prospective financial information, growth rates, discount rates and comparable multiples from publicly traded companies in similar industries. An impairment charge is recorded for the amount by which the carrying amount of goodwill exceeds its fair value.
The table below reflects the calculation of net debt for the periods presented: (dollars in thousands) January 29, 2022 January 30, 2021 Total debt: Senior secured credit facilities, net, including current portion $ 1,657,390 $ 1,646,281 Finance leases, including current portion 29,816 13,639 Total debt $ 1,687,206 $ 1,659,920 Less: cash and cash equivalents (211,602 ) (111,402 ) Net Debt $ 1,475,604 $ 1,548,518 Liquidity and Capital Resources Overview Our primary sources of liquidity are funds generated by operating activities and available capacity for borrowings on our $500 million secured asset-based revolving credit facility maturing March 4, 2026 (the “ABL Revolving Credit Facility”).
The table below reflects the calculation of Free Cash Flow for the periods presented: Fiscal years ended January 28, 2023 January 29, 2022 January 30, 2021 (dollars in thousands) (52 weeks) (52 weeks) (52 weeks) Net cash provided by operating activities $ 346,003 $ 358,215 $ 268,615 Cash paid for fixed assets (278,020 ) (239,110 ) (159,560 ) Free Cash Flow $ 67,983 $ 119,105 $ 109,055 Liquidity and Capital Resources Overview Our primary sources of liquidity are funds generated by operating activities and available capacity for borrowings on our $500 million secured asset-based revolving credit facility maturing March 4, 2026 (the “ABL Revolving Credit Facility”).
( 3 ) Non-recurring costs include: severance; legal reserves and related fees; one-time consulting and other costs associated with the Company’s strategic transformation initiatives; discontinuation and liquidation costs; and costs related to our initial public offering and refinancing.
In fiscal 2022, approximately $8.2 million of these integration costs was recorded in cost of sales, and $7.1 million of these integration costs was recorded in selling, general and administrative expenses. 54 (5) Other costs prior to fiscal 2023 included: severance; legal reserves and related fees; one-time consulting and other costs associated with our strategic transformation initiatives; discontinuation and liquidation costs; and costs related to our initial public offering and refinancing.
In fiscal 2020 and fiscal 2021, U.S. households welcomed millions of incremental new pets into their homes that will need to be fed, groomed, vaccinated, and treated during their lives. Customer Pet Purchase Trends Our multi-channel integrated ecosystem is designed to support our customers regardless of how customers choose to shop for their pet care needs.
Importantly, the majority of these new pet parents came from Millennial and Gen Z generations, who typically spend more on their pets. Customer Pet Purchase Trends Our multi-channel integrated ecosystem is designed to support our customers regardless of how customers choose to shop for their pet care needs.
Sales channel impacts driven by strength in our digital, services and vet business, and moderate increases in distribution costs also contributed to the decrease in gross profit rate during fiscal 2021 as compared to fiscal 2020.
The decrease in gross profit rate in fiscal 2022 as compared to fiscal 2021 was primarily driven by the mix impact of strength in consumables sales and lower supplies and companion animal sales combined with elevated supply chain costs.